Advanced Immunological Approach in COPD Exacerbation

Clinical trial NCT02417649 · COMPLETED

Trial details

NCT number: NCT02417649
Sponsor: Lallemand Pharma AG
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2009-09-01
Primary completion: 2013-07-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.